Company says it will continue to operate as a standalone company on a macro perspective.
Happy demi-anniversary, stock market rally. Will the honeymoon ever end?
Watson Pharmaceuticals expects no change on a macro level with Actavis
Theflyonthewall.com – Mon, Apr 30, 2012 8:52 AM EDTRelated Content
- Drugmaker Actavis' shares up
- Ahead of the Bell: Drugmaker Actavis' shares up
- Ahead of the Bell: Warner Chilcott
- Actavis rejected $15 billion offer from Mylan: source
- Global Macro: The 'New Normal' in Markets
- Keep an Eye on Free Cash Flow in 2013
- Surprise! The US will borrow $200 billion less than expected this year
- First Person: I Expect Online Purchases to Be Taxed
- MORGAN STANLEY: The Tesla Debate Has Changed
- 21Vianet sees Q2 revenue RMB465M-RMB472M.
- May 13: Retail Sales Better Than Expected
- Final Glance: Pharmaceuticals companies
- Actavis posts 1Q loss on deal costs; lifts outlook
- Actavis, Warner Chilcott discussing combination
Recent Quotes Symbol Price Change % Chg Chart Your most recently viewed tickers will automatically show up here if you type a ticker in the "Enter symbol/company" at the bottom of this module.Recent Quotes News
- Sign-in to view quotes in your portfolios.
Rally Gives Investors a Great Year, in Just 6 MonthsMichael Santoli- How the Obamas Manage Their MoneyThe Exchange
- Satomi Kawakita Jewelry: Turning Passion Into ProfitsYahoo! Finance
Trading Center
Today on Yahoo!
1 - 6 of 42
Yahoo! Finance on Facebook
@YahooFinance on Twitter
POLL
What would you like to see out of any potential tax reforms?
Loading...